Iga Waluszewska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iga Waluszewska has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Antoni Borowiec
Students’ Scientific Society, Department of Pharmacology, Faculty of Medicine, University of Opole, 45-052 Opole, Poland
4 shared publications - Wioletta Szczurek-Wasilewicz
Department of Pharmacology, Faculty of Medicine, University of Opole, 45-052 Opole, Poland
3 shared publications - Agata Kawalec
Department of Anatomy, Institute of Medical Sciences, University of Opole, Oleska St. 48, 45-052 Opole, Poland
1 shared publication - Alicja Paciorek
Students’ Scientific Society, Department of Pharmacology, Faculty of Medicine, University of Opole, 45-052 Opole, Poland
1 shared publication - Bożena Szyguła-Jurkiewicz
3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
1 shared publication - Letycja Musz
Students’ Scientific Society, Department of Pharmacology, Faculty of Medicine, University of Opole, 45-052 Opole, Poland
1 shared publication
Latest Publications
- Open Access
- 23 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7545
The Liver as a Biomarker Organ in Heart Failure: Molecular Mechanisms, Hepatic Scores and Systemic Risk Stratification
Heart failure (HF) is a systemic syndrome in which prognosis depends on cardiac dysfunction, congestion, cardiorenal and cardiohepatic interactions, inflammation, and metabolic dysregulation. The liver is exposed to elevated systemic venous pressure and reduced forward flow, and contributes to albumin and coagulation factor synthesis, bile acid metabolism, iron homeostasis, and the acute-phase response. Cardiohepatic injury involves hemodynamic stress, sinusoidal endothelial dysfunction, oxidative stress, inflammatory signaling, fibrogenesis, and altered metabolic regulation. Congestive hepatopathy is associated with right-sided HF, tricuspid regurgitation (TR), pulmonary hypertension, and elevated central venous pressure, whereas hypoxic hepatitis develops during low-output states, shock, or acute circulatory deterioration. These mechanisms may coexist, producing congestive/cholestatic, hypoperfusive/ischemic and mixed/systemic reserve profiles. Composite liver-related scores, including Model for End-Stage Liver Disease (MELD), MELD excluding International Normalized Ratio (MELD-XI), MELD with sodium (MELD-Na), MELD-Albumin and albumin–bilirubin (ALBI) score, may reflect congestion, hepatorenal dysfunction, nutritional status and reduced systemic reserve. This review summarizes hemodynamic and molecular mechanisms of cardiohepatic injury, liver-related biomarkers and composite scores, with emphases on advanced HF, left ventricular assist device (LVAD) therapy and heart transplantation. Liver-related abnormalities remain underrecognized in HF. Their serial interpretation may support risk stratification, but composite scores should complement rather than replace comprehensive clinical assessment.
- 23 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7545
Open AccessThe Liver as a Biomarker Organ in Heart Failure: Molecular Mechanisms, Hepatic Scores and Systemic Risk Stratification
Heart failure (HF) is a systemic syndrome in which prognosis depends on cardiac dysfunction, congestion, cardiorenal and cardiohepatic interactions, inflammation, and metabolic dysregulation. The liver is exposed to elevated systemic venous pressure and reduced forward flow, and contributes to albumin and coagulation factor synthesis, bile acid metabolism, iron homeostasis, and the acute-phase response. Cardiohepatic injury involves hemodynamic stress, sinusoidal endothelial dysfunction, oxidative stress, inflammatory signaling, fibrogenesis, and altered metabolic regulation. Congestive hepatopathy is associated with right-sided HF, tricuspid regurgitation (TR), pulmonary hypertension, and elevated central venous pressure, whereas hypoxic hepatitis develops during low-output states, shock, or acute circulatory deterioration. These mechanisms may coexist, producing congestive/cholestatic, hypoperfusive/ischemic and mixed/systemic reserve profiles. Composite liver-related scores, including Model for End-Stage Liver Disease (MELD), MELD excluding International Normalized Ratio (MELD-XI), MELD with sodium (MELD-Na), MELD-Albumin and albumin–bilirubin (ALBI) score, may reflect congestion, hepatorenal dysfunction, nutritional status and reduced systemic reserve. This review summarizes hemodynamic and molecular mechanisms of cardiohepatic injury, liver-related biomarkers and composite scores, with emphases on advanced HF, left ventricular assist device (LVAD) therapy and heart transplantation. Liver-related abnormalities remain underrecognized in HF. Their serial interpretation may support risk stratification, but composite scores should complement rather than replace comprehensive clinical assessment.
- Open Access
- 16 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 201
Cardiovascular Safety of Hormonal Contraception: Method-Specific Risks and Clinical Implications
Hormonal contraception is used by hundreds of millions of women worldwide and remains one of the most effective reversible methods of pregnancy prevention. Cardiovascular (CV) safety concerns, particularly venous thromboembolism (VTE), ischemic stroke, myocardial infarction, and blood pressure elevation, are important considerations when choosing forms of contraception. Estrogen-containing combined hormonal contraceptives (CHCs) increase the relative risk of VTE; however, among healthy young nonsmokers, absolute event rates remain low. Risk is strongly modified by estrogen dose, progestin type, route of administration, and individual factors such as age, smoking, migraine with aura, hypertension, obesity, inherited thrombophilia, the postpartum period, and concomitant prothrombotic medications. Progestin-only contraceptives and levonorgestrel-releasing intrauterine systems (LNG-IUSs) generally show a more favorable thrombotic profile and are preferred options for women with contraindications for estrogen. This review summarizes current evidence on the method-specific CV risks of hormonal contraception, highlights the mechanisms underlying these effects, and provides practical guidance for clinical decision-making.
- 16 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 201
Open AccessCardiovascular Safety of Hormonal Contraception: Method-Specific Risks and Clinical Implications
Hormonal contraception is used by hundreds of millions of women worldwide and remains one of the most effective reversible methods of pregnancy prevention. Cardiovascular (CV) safety concerns, particularly venous thromboembolism (VTE), ischemic stroke, myocardial infarction, and blood pressure elevation, are important considerations when choosing forms of contraception. Estrogen-containing combined hormonal contraceptives (CHCs) increase the relative risk of VTE; however, among healthy young nonsmokers, absolute event rates remain low. Risk is strongly modified by estrogen dose, progestin type, route of administration, and individual factors such as age, smoking, migraine with aura, hypertension, obesity, inherited thrombophilia, the postpartum period, and concomitant prothrombotic medications. Progestin-only contraceptives and levonorgestrel-releasing intrauterine systems (LNG-IUSs) generally show a more favorable thrombotic profile and are preferred options for women with contraindications for estrogen. This review summarizes current evidence on the method-specific CV risks of hormonal contraception, highlights the mechanisms underlying these effects, and provides practical guidance for clinical decision-making.
- Open Access
- 30 March 2026
- Published by John Paul II University in Biała Podlaska in Rozprawy Społeczne
- Vol. 20 (1) , 35-45
Language awareness of medical students in the context of selected anatomical terms considered stigmatizing – a pilot study
Streszczenie: Celem badania była ocena stopnia znajomości i stosowania potencjalnie stygmatyzujących terminów anatomicznych przez studentów kierunku lekarskiego. Materiał i metody: Badanie pilotażowe przeprowadzono w formie anonimowej ankiety wśród 72 studentów kierunku lekarskiego w maju 2025 roku. Zebrane dane opracowano przy użyciu programów Excel oraz PAST. Wyniki: Analiza wyników wykazała, że znaczna część respondentów posługiwała się terminologią niezalecaną lub znała wyłącznie określenia nacechowane pejoratywnie. Nie stwierdzono istotnych różnic w zakresie stosowanej terminologii między studentami młodszych i starszych lat studiów. Świadomość możliwości występowania cech takich jak pojedyncza bruzda dłoniowa czy zmarszczka nakątna u osób z prawidłowym kariotypem również była ograniczona. Wnioski: Wyniki badania wskazują na potrzebę integracji zagadnień świadomości językowej, inkluzywnej terminologii medycznej w programie kształcenia na kierunku lekarskim. Konieczne wydaje się także przeanalizowanie materiałów dydaktycznych oraz większe zaangażowanie kadry akademickiej w promowanie neutralnego i empatycznego języka. Badanie ujawnia lukę w edukacji medycznej dotyczącą języka opisu cech anatomicznych.
- 30 March 2026
- Published by John Paul II University in Biała Podlaska in Rozprawy Społeczne
- Vol. 20 (1) , 35-45
Open AccessLanguage awareness of medical students in the context of selected anatomical terms considered stigmatizing – a pilot study
Streszczenie: Celem badania była ocena stopnia znajomości i stosowania potencjalnie stygmatyzujących terminów anatomicznych przez studentów kierunku lekarskiego. Materiał i metody: Badanie pilotażowe przeprowadzono w formie anonimowej ankiety wśród 72 studentów kierunku lekarskiego w maju 2025 roku. Zebrane dane opracowano przy użyciu programów Excel oraz PAST. Wyniki: Analiza wyników wykazała, że znaczna część respondentów posługiwała się terminologią niezalecaną lub znała wyłącznie określenia nacechowane pejoratywnie. Nie stwierdzono istotnych różnic w zakresie stosowanej terminologii między studentami młodszych i starszych lat studiów. Świadomość możliwości występowania cech takich jak pojedyncza bruzda dłoniowa czy zmarszczka nakątna u osób z prawidłowym kariotypem również była ograniczona. Wnioski: Wyniki badania wskazują na potrzebę integracji zagadnień świadomości językowej, inkluzywnej terminologii medycznej w programie kształcenia na kierunku lekarskim. Konieczne wydaje się także przeanalizowanie materiałów dydaktycznych oraz większe zaangażowanie kadry akademickiej w promowanie neutralnego i empatycznego języka. Badanie ujawnia lukę w edukacji medycznej dotyczącą języka opisu cech anatomicznych.
- Open Access
- 14 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11037
Impact of Anabolic–Androgenic Steroid Abuse on the Cardiovascular System: Molecular Mechanisms and Clinical Implications
Anabolic–androgenic steroids (AAS) are synthetic derivatives of testosterone that are used therapeutically but are frequently abused by athletes and individuals seeking to increase muscle mass. Their anabolic (promoting muscle growth) and androgenic (inducing masculine characteristics) effects result from androgen receptor activation in target tissues. However, chronic supraphysiological AAS exposure is associated with serious cardiovascular consequences, ranging from hypertension and lipid disorders to cardiomyopathy, atherosclerosis, and sudden cardiac death. This review provides an updated and integrative perspective on both the molecular and clinical aspects of AAS-induced cardiovascular toxicity, highlighting recent advances in understanding endothelial injury, oxidative stress, fibrosis, and arrhythmogenesis. Importantly, it emphasizes the emerging recognition of AAS abuse as a modifiable cardiovascular risk factor and discusses potential preventive and therapeutic strategies, including early cardiovascular screening and risk stratification. Understanding these mechanisms is essential for recognizing the clinical manifestations of AAS misuse and for improving cardiovascular risk assessment in affected individuals. These insights underscore the clinical significance of AAS abuse as a cardiovascular risk factor and the need for vigilant cardiac monitoring and early intervention in this population.
- 14 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11037
Open AccessImpact of Anabolic–Androgenic Steroid Abuse on the Cardiovascular System: Molecular Mechanisms and Clinical Implications
Anabolic–androgenic steroids (AAS) are synthetic derivatives of testosterone that are used therapeutically but are frequently abused by athletes and individuals seeking to increase muscle mass. Their anabolic (promoting muscle growth) and androgenic (inducing masculine characteristics) effects result from androgen receptor activation in target tissues. However, chronic supraphysiological AAS exposure is associated with serious cardiovascular consequences, ranging from hypertension and lipid disorders to cardiomyopathy, atherosclerosis, and sudden cardiac death. This review provides an updated and integrative perspective on both the molecular and clinical aspects of AAS-induced cardiovascular toxicity, highlighting recent advances in understanding endothelial injury, oxidative stress, fibrosis, and arrhythmogenesis. Importantly, it emphasizes the emerging recognition of AAS abuse as a modifiable cardiovascular risk factor and discusses potential preventive and therapeutic strategies, including early cardiovascular screening and risk stratification. Understanding these mechanisms is essential for recognizing the clinical manifestations of AAS misuse and for improving cardiovascular risk assessment in affected individuals. These insights underscore the clinical significance of AAS abuse as a cardiovascular risk factor and the need for vigilant cardiac monitoring and early intervention in this population.